The evolution of biosensors has piqued the interest of researchers, scientists, and investors in the last few decades. With the constant development of biosensors
, the devices have emerged as detection equipment to assess the presence of chemicals in living organisms, antibodies, biological molecules, or enzymes.
Biosensors have garnered substantial importance in the discovery of several drugs and have increased their significance in biopharmaceutical product monitoring development and the field of next screening.
Biosensors Transforms Drug Analysis and Drug Delivery
Many research groups and biotech companies have recently investigated several novel biosensors with high sensitivity, including immunosensors, enzyme-based, tissue-based, enzyme-based, DNA biosensors, piezoelectric, and thermal biosensors. These biosensors offer numerous advantages, including exceptional sensitivity, low-cost instrumentation, operational simplicity, automation potential, and inherent miniaturization.
They have provided elegant pathways for the identification of even trace amounts of analytical agents of biological significance, ranging from macromolecules (e.g., antigens and disease biomarkers) and small molecules (e.g., haptens and natural toxins) to bacteria, cells, and viruses.
The use of biosensing has become critical in the fields of drug discovery,
biomedicine, drug analysis, and pharmacology. This growing importance of biosensing has resulted in the development of precise, reliable, and powerful analytical tools based on biological sensing elements, such as biosensors.
On account of this, the demand for biosensors is forecast to create a dollar opportunity of around $25 billion by 2030's end. With this growing significance in the pharmaceutical and medical industries, a substantial rise in research and development for biosensors is being witnessed all over the world.
The Road Ahead
In recent years, there has been a lot of interest in the development of biosensors for analytical purposes, increasing the applications of biosensors in resolving a potentially large number of analytical challenges and problems across various pharmaceutical and medical domains.
Also, prominent companies are focusing on the introduction of advanced wearable biosensors, integrated with innovative technologies such as the Internet of Things
(IoT) for real-time data availability. This will assist in making better clinical decisions and early detection of health events.